These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 28918671)
81. Twenty-Five Years of Gene Therapy for ADA-SCID: From Bubble Babies to an Approved Drug. Ferrua F; Aiuti A Hum Gene Ther; 2017 Nov; 28(11):972-981. PubMed ID: 28847159 [TBL] [Abstract][Full Text] [Related]
82. Screening for and treatments of congenital immunodeficiency diseases. Verbsky J; Routes J Clin Perinatol; 2014 Dec; 41(4):1001-15. PubMed ID: 25459787 [TBL] [Abstract][Full Text] [Related]
83. Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases. Nishimura A; Aoki Y; Ishiwata Y; Ichimura T; Ueyama J; Kawahara Y; Tomoda T; Inoue M; Matsumoto K; Inoue K; Hiroki H; Ono S; Yamashita M; Okano T; Tanaka-Kubota M; Ashiarai M; Miyamoto S; Miyawaki R; Yamagishi C; Tezuka M; Okawa T; Hoshino A; Endo A; Yasuhara M; Kamiya T; Mitsuiki N; Ono T; Isoda T; Yanagimachi M; Tomizawa D; Nagasawa M; Mizutani S; Kajiwara M; Takagi M; Kanegane H; Imai K; Morio T J Clin Immunol; 2021 Jul; 41(5):944-957. PubMed ID: 33527309 [TBL] [Abstract][Full Text] [Related]
86. Diagnostic Criteria and Evaluation of Severe Combined Immunodeficiency in the Neonate. Diamond CE; Sanchez MJ; LaBelle JL Pediatr Ann; 2015 Jul; 44(7):e181-7. PubMed ID: 26171708 [TBL] [Abstract][Full Text] [Related]
87. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. Kwan A; Church JA; Cowan MJ; Agarwal R; Kapoor N; Kohn DB; Lewis DB; McGhee SA; Moore TB; Stiehm ER; Porteus M; Aznar CP; Currier R; Lorey F; Puck JM J Allergy Clin Immunol; 2013 Jul; 132(1):140-50. PubMed ID: 23810098 [TBL] [Abstract][Full Text] [Related]
88. [Severe combined immunodeficiency: From its discovery to the perspective]. Kanegane H; Imai K; Morio T Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):145-154. PubMed ID: 28747600 [TBL] [Abstract][Full Text] [Related]
89. Swiss newborn screening for severe T and B cell deficiency with a combined TREC/KREC assay - management recommendations. Trück J; Prader S; Natalucci G; Hagmann C; Brotschi B; Kelly J; Bassler D; Steindl K; Rauch A; Baumgartner M; Fingerhut R; Hauri-Hohl M; Güngör T; Pachlopnik Schmid J; Berger C; Reichenbach J Swiss Med Wkly; 2020 Jun; 150():w20254. PubMed ID: 32579701 [TBL] [Abstract][Full Text] [Related]
90. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Kalman L; Lindegren ML; Kobrynski L; Vogt R; Hannon H; Howard JT; Buckley R Genet Med; 2004; 6(1):16-26. PubMed ID: 14726805 [TBL] [Abstract][Full Text] [Related]
91. Newborn Screening for Severe Combined Immunodeficiency in the United States: Lessons Learned. Dorsey MJ; Puck JM Immunol Allergy Clin North Am; 2019 Feb; 39(1):1-11. PubMed ID: 30466767 [TBL] [Abstract][Full Text] [Related]
92. Successful newborn screening for SCID in the Navajo Nation. Kwan A; Hu D; Song M; Gomes H; Brown DR; Bourque T; Gonzalez-Espinosa D; Lin Z; Cowan MJ; Puck JM Clin Immunol; 2015 May; 158(1):29-34. PubMed ID: 25762520 [TBL] [Abstract][Full Text] [Related]
94. Hematopoietic stem cell transplantation for severe combined immunodeficiency. Hönig M; Schulz A; Friedrich W Klin Padiatr; 2011 Nov; 223(6):320-5. PubMed ID: 22052630 [TBL] [Abstract][Full Text] [Related]
95. Stem cell transplantation for primary immunodeficiency diseases: the North American experience. Pai SY; Cowan MJ Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):521-6. PubMed ID: 25259542 [TBL] [Abstract][Full Text] [Related]
96. A Droplet Digital PCR Method for Severe Combined Immunodeficiency Newborn Screening. Vidal-Folch N; Milosevic D; Majumdar R; Gavrilov D; Matern D; Raymond K; Rinaldo P; Tortorelli S; Abraham RS; Oglesbee D J Mol Diagn; 2017 Sep; 19(5):755-765. PubMed ID: 28826609 [TBL] [Abstract][Full Text] [Related]
97. Severe combined immunodeficiency: new advances in diagnosis and treatment. Puck JM Immunol Res; 2007; 38(1-3):64-7. PubMed ID: 17917011 [TBL] [Abstract][Full Text] [Related]
98. Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning. Otsu M; Yamada M; Nakajima S; Kida M; Maeyama Y; Hatano N; Toita N; Takezaki S; Okura Y; Kobayashi R; Matsumoto Y; Tatsuzawa O; Tsuchida F; Kato S; Kitagawa M; Mineno J; Hershfield MS; Bali P; Candotti F; Onodera M; Kawamura N; Sakiyama Y; Ariga T J Clin Immunol; 2015 May; 35(4):384-98. PubMed ID: 25875699 [TBL] [Abstract][Full Text] [Related]
99. Severe combined immunodeficiency diagnosis and genetic defects. Aranda CS; Gouveia-Pereira MP; da Silva CJM; Rizzo MCFV; Ishizuka E; de Oliveira EB; Condino-Neto A Immunol Rev; 2024 Mar; 322(1):138-147. PubMed ID: 38287514 [TBL] [Abstract][Full Text] [Related]
100. Newborn screening for severe combined immunodeficiency: The results of the first pilot TREC and KREC study in Ukraine with involving of 10,350 neonates. Boyarchuk O; Yarema N; Kravets V; Shulhai O; Shymanska I; Chornomydz I; Hariyan T; Volianska L; Kinash M; Makukh H Front Immunol; 2022; 13():999664. PubMed ID: 36189201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]